Anna Sediva

vice-head

University Hospital in Motol

Czech Republic

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anna Sediva is the Vice-Head at Motol University Hospital in the Czech Republic. Her research areas focus on immunology, particularly in relation to pediatric inflammatory conditions, PI3Kδ syndrome, and the immune response to COVID-19. She has authored and contributed to multiple significant articles addressing the management and diagnosis of immunodeficiencies and related syndromes.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Ellen Tufvesson

SWEDEN

View details

Milena Sokolowska

SWITZERLAND

View details

Paige Lacy

Professor

University of Alberta

CANADA

View details

Rodrigo Jiménez‐Saiz

SPAIN

View details

Leo Koenderman

NETHERLANDS

View details

Andrzej Eljaszewicz

Medical University of Bialystok

POLAND

View details

Wojciech Feleszko

Associate Professor, Consultant Clinical Immunologist

POLAND

View details

Manali Mukherjee

Assistant Professor

McMaster University

CANADA

View details

Cristina Gomez‐Casado

SPAIN

View details

Zuzana Diamant

Guest Professor

Catholic University of Leuven

BELGIUM

View details

Sven Seys

Chief Scientific Officer

Hippo Dx

BELGIUM

View details

Jiří Litzman

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Sediva

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

Eosinophils—from cradle to grave

Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Medical algorithm: Diagnosis and management of antibody immunodeficiencies

The Konya Declaration for Patients with Primary Immunodeficiencies

Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes

Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID‐19 pandemic: A statement from the EAACI‐section on pediatrics

Collaborators (12)

Ellen Tufvesson

Milena Sokolowska

Paige Lacy

Rodrigo Jiménez‐Saiz

Leo Koenderman

Andrzej Eljaszewicz

Wojciech Feleszko

Manali Mukherjee

Cristina Gomez‐Casado

Zuzana Diamant

Sven Seys

Jiří Litzman

Make your next move.